These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 17404783)

  • 1. Effects of an educational-behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial.
    Masiero S; Boniolo A; Wassermann L; Machiedo H; Volante D; Punzi L
    Clin Rheumatol; 2007 Dec; 26(12):2043-2050. PubMed ID: 17404783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term outcomes from a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis.
    Hammond A; Freeman K
    Clin Rehabil; 2004 Aug; 18(5):520-8. PubMed ID: 15293486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of therapeutic education for patients with rheumatoid arthritis.
    Abourazzak F; El Mansouri L; Huchet D; Lozac'hmeur R; Hajjaj-Hassouni N; Ingels A; Chalès G; Perdriger A
    Joint Bone Spine; 2009 Dec; 76(6):648-53. PubMed ID: 19775924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year outcomes of a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis.
    Hammond A; Freeman K
    Rheumatology (Oxford); 2001 Sep; 40(9):1044-51. PubMed ID: 11561117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire.
    Barra L; Pope JE; Payne M
    J Rheumatol; 2009 Jul; 36(7):1421-8. PubMed ID: 19487267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.
    Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M
    Value Health; 2015 Dec; 18(8):1008-15. PubMed ID: 26686785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
    Pease C; Pope JE; Truong D; Bombardier C; Widdifield J; Thorne JC; Paul Haraoui B; Psaradellis E; Sampalis J; Bonner A
    Semin Arthritis Rheum; 2011 Aug; 41(1):81-9. PubMed ID: 21168187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis.
    Nagasawa H; Kameda H; Sekiguchi N; Amano K; Takeuchi T
    Mod Rheumatol; 2010 Aug; 20(4):337-42. PubMed ID: 20225006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of needs-based patient education on self-efficacy and health outcomes in people with rheumatoid arthritis: a multicentre, single blind, randomised controlled trial.
    Ndosi M; Johnson D; Young T; Hardware B; Hill J; Hale C; Maxwell J; Roussou E; Adebajo A
    Ann Rheum Dis; 2016 Jun; 75(6):1126-32. PubMed ID: 26162769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.
    Breedveld FC; Han C; Bala M; van der Heijde D; Baker D; Kavanaugh AF; Maini RN; Lipsky PE
    Ann Rheum Dis; 2005 Jan; 64(1):52-5. PubMed ID: 15286005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Education, self-management, and upper extremity exercise training in people with rheumatoid arthritis: a randomized controlled trial.
    Manning VL; Hurley MV; Scott DL; Coker B; Choy E; Bearne LM
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):217-27. PubMed ID: 23925924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression.
    Dirven L; Visser K; Klarenbeek NB; Ewals JA; Han KH; Peeters AJ; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Scand J Rheumatol; 2012 Feb; 41(1):15-9. PubMed ID: 22103436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients.
    Flint-Wagner HG; Lisse J; Lohman TG; Going SB; Guido T; Cussler E; Gates D; Yocum DE
    J Clin Rheumatol; 2009 Jun; 15(4):165-71. PubMed ID: 19279507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Recent-Onset Arthritis Disability questionnaire with the Health Assessment Questionnaire disability index in patients with rheumatoid arthritis.
    Salaffi F; Ciapetti A; Gasparini S; Migliore A; Scarpellini M; Corsaro SM; Laganà B; Mozzani F; Varcasia G; Pusceddu M; Castriotta M; Serale F; Maier A; Foti R; Scarpa R; Bombardieri S;
    Clin Exp Rheumatol; 2010; 28(6):855-65. PubMed ID: 21122262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment.
    ten Klooster PM; Veehof MM; Taal E; van Riel PL; van de Laar MA
    Ann Rheum Dis; 2007 Nov; 66(11):1485-90. PubMed ID: 17472993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
    Keystone EC; Kavanaugh AF; Sharp JT; Tannenbaum H; Hua Y; Teoh LS; Fischkoff SA; Chartash EK
    Arthritis Rheum; 2004 May; 50(5):1400-11. PubMed ID: 15146409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial.
    Bingham CO; Weinblatt M; Han C; Gathany TA; Kim L; Lo KH; Baker D; Mendelsohn A; Westhovens R
    J Rheumatol; 2014 Jun; 41(6):1067-76. PubMed ID: 24786931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rehabilitation treatment in patients with ankylosing spondylitis stabilized with tumor necrosis factor inhibitor therapy: a randomized controlled trial.
    Masiero S; Bonaldo L; Pigatto M; Lo Nigro A; Ramonda R; Punzi L
    J Rheumatol; 2011 Jul; 38(7):1335-42. PubMed ID: 21459942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.